Subscribe
shutterstock_664142593_jonathan_weiss-1
Jonathan Weiss / Shutterstock.com
13 August 2019AmericasSarah Morgan

Fed Circ affirms Eli Lilly victories over cancer drugs

The US Court of Appeals for the Federal Circuit last week affirmed two findings that Dr Reddy’s and Hospira had infringed Eli Lilly’s cancer drug Alimta (pemetrexed).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Eli Lilly and Eagle Pharma settle antitrust and infringement claims
18 December 2019   US-based Eagle Pharmaceuticals has dropped its patent infringement and antitrust claims against Eli Lilly.
Americas
SCOTUS refuses to hear Eli Lilly patent win
16 June 2020   The US Supreme Court has declined to review Eli Lilly’s patent infringement victory against Dr Reddy’s and Hospira.
Americas
Eli Lilly seals $1bn genetics deal
17 December 2020   Eli Lilly is expanding its genetics business with the $880 million purchase of Prevail Therapeutics, in a deal that could rise to more than $1 billion.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024
Americas
Comparing life sciences IP in Brazil and the US
28 November 2024
Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024

More on this story

Big Pharma
Eli Lilly and Eagle Pharma settle antitrust and infringement claims
18 December 2019   US-based Eagle Pharmaceuticals has dropped its patent infringement and antitrust claims against Eli Lilly.
Americas
SCOTUS refuses to hear Eli Lilly patent win
16 June 2020   The US Supreme Court has declined to review Eli Lilly’s patent infringement victory against Dr Reddy’s and Hospira.
Americas
Eli Lilly seals $1bn genetics deal
17 December 2020   Eli Lilly is expanding its genetics business with the $880 million purchase of Prevail Therapeutics, in a deal that could rise to more than $1 billion.

More on this story

Big Pharma
Eli Lilly and Eagle Pharma settle antitrust and infringement claims
18 December 2019   US-based Eagle Pharmaceuticals has dropped its patent infringement and antitrust claims against Eli Lilly.
Americas
SCOTUS refuses to hear Eli Lilly patent win
16 June 2020   The US Supreme Court has declined to review Eli Lilly’s patent infringement victory against Dr Reddy’s and Hospira.
Americas
Eli Lilly seals $1bn genetics deal
17 December 2020   Eli Lilly is expanding its genetics business with the $880 million purchase of Prevail Therapeutics, in a deal that could rise to more than $1 billion.

More features

Fed Circ orders Teva to delist five patents from Orange Book
Sarepta wins $115M in patent dispute over muscular dystrophy drug
Novartis shields eye-drop patent at European Patent Office
CREATES Act unfairly tips the scales to generics
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York